Experience in personifying the standard treatment of patients with hemophilia A: results of a multicenter Russian open-labeled prospective study evaluating the use of haemoctin

Aim. To evaluate the clinical efficiency, tolerability, safety, and immunogenicity of replacement therapy with haemoctin SDH (Biotest Pharma GmbH, Germany) in pretreated patients with hemophilia A (HA). Subjects and methods. The pretreated patients (n = 140) with varying GA from 12 regions of the Ru...

Full description

Bibliographic Details
Main Authors: Nadezhda Ivanovna Zozulya, Ol'ga Pavlovna Plyushch, N I Zozulya, O P Plyushch
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2010-04-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/30603